Wealthcare Advisory Partners LLC

SEC CIK: 0001683059
Latest filing: Jul 9, 2026

SEC filings (opens in a new tab)

ACXP holding history

Acurx Pharmaceuticals, Inc. in every 13F filed by Wealthcare Advisory Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACXP overview All 13F holders of ACXP Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q2 2025

Holdings of ACXP by Wealthcare Advisory Partners LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−577−100.0%	Sold outConverted for a 1-for-20 split	Holders
Q2 2025	11,538	$5.89K	<0.1%	+11,538	New	Holders